Abstract:Background: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive age women. Although its cardinal manifestations include hyperandrogenism, oligo/anovulation, and/or polycystic ovarian morphology, PCOS women often display also notable metabolic comorbidities. An array of pathogenic mechanisms have been implicated in the etiology of this heterogeneous endocrine disorder; hyperandrogenism at various developmental periods is proposed as a major driver of the metabolic and reproductive perturbations associated with PCOS. However, the current understanding of the pathophysiology of PCOS-associated metabolic disease is incomplete, and therapeutic strategies used to manage this syndrome's metabolic complications remain limited. Scope of review: This study is a systematic review of the potential etiopathogenic mechanisms of metabolic dysfunction frequently associated with PCOS, with special emphasis on the metabolic impact of androgen excess on different metabolic tissues and the brain. We also briefly summarize the therapeutic approaches currently available to manage metabolic perturbations linked to PCOS, highlighting current weaknesses and future directions. Major conclusions: Androgen excess plays a prominent role in the development of metabolic disturbances associated with PCOS, with a discernible impact on key peripheral metabolic tissues, including the adipose, liver, pancreas, and muscle, and very prominently the brain, contributing to the constellation of metabolic complications of PCOS, from obesity to insulin resistance. However, the current understanding of the pathogenic roles of hyperandrogenism in metabolic dysfunction of PCOS and the underlying mechanisms remain largely incomplete. In addition, the development of more efficient, even personalized therapeutic strategies for the metabolic management of PCOS patients persists as an unmet need that will certainly benefit from a better comprehension of the molecular basis of this heterogeneous syndrome.

Androgen, Androgen Receptor and Polycystic Ovary Syndrome

Alternative Splicing of the Androgen Receptor in Polycystic Ovary Syndrome

The Casein Kinase 2α Promotes the Occurrence Polycystic Ovary Syndrome.

Hyperandrogenism Involved in Pathogenesis of Polycystic Ovary Syndrome

The Mechanism of Androgen Actions in PCOS Etiology

The interplay between androgens and the immune response in polycystic ovary syndrome

Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome

Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature

A Molecular and Cellular Review of the Literature

A Molecular Mechanism Underlying Ovarian Dysfunction of Polycystic Ovary Syndrome: Hyperandrogenism Induces Epigenetic Alterations in the Granulosa Cells

[Research Progress in the Pathogenesis of Polycystic Ovary Syndrome]

[Long-Term Effects of Polycystic Ovary Syndrome on the Offspring].

Advances in Molecular Genetic Study on PCOS

Roles of estrogen and its receptors in polycystic ovary syndrome

Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review

Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome

Research status of polycystic ovary syndrome and endometrial hyperplasia

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies

Research Advances in the Role of Inflammatory Factors in Polycystic Ovary Syndrome

The Roles of Autophagy in the Genesis and Development of Polycystic Ovary Syndrome